Literature DB >> 20674404

Predicting risk for bisphosphonate-related osteonecrosis of the jaws: CTX versus radiographic markers.

Kenneth E Fleisher1, Garrett Welch, Shailesh Kottal, Ronald G Craig, Deepak Saxena, Robert S Glickman.   

Abstract

BACKGROUND AND
OBJECTIVE: The most common risk factor for bisphosphonate-related osteonecrosis of the jaws (BRONJ) is dentoalveolar surgery. It has been suggested that reduced serum C-terminal telopeptide (CTX) can determine the degree of osteoclast suppression and may predict the development of BRONJ after dentoalveolar surgery. Although there are many radiographic appearances associated with BRONJ, there are little data that describes changes preceding dentoalveolar surgery. The objective of this retrospective study was: 1) to investigate if reduced serum CTX values (i.e., <150 pg/mL) were associated with BRONJ after dentoalveolar surgery; and 2) to determine if specific radiographic changes are associated with teeth that develop BRONJ after extraction. STUDY
DESIGN: A retrospective review of radiographic and/or serum CTX data was performed for 68 patients with a history of bisphosphonate therapy who either underwent dental extraction or were diagnosed with BRONJ in the Department of Oral and Maxillofacial Surgery during the period 2007-2009. Postoperative healing was assessed for 26 patients with reduced serum CTX levels (<150 pg/mL) who either underwent dental extraction or treatment for BRONJ. Preoperative radiographs were evaluated for 55 patients who either healed normally or developed BRONJ after dental extraction.
RESULTS: All 26 patients (100%) who had serum CTX levels <150 pg/mL healed successfully after dentoalveolar surgery (20 patients) or after treatment for BRONJ (6 patients). Among the 55 patients who underwent radiographic evaluation, 24 patients (83%) with BRONJ exhibited periodontal ligament (PDL) widening associated with extracted teeth, whereas only 3 patients (11%) who healed normally demonstrated PDL widening.
CONCLUSION: These data suggest that radiographic PDL widening may be a more sensitive indicator than CTX testing in predicting risk of BRONJ. Current guidelines that recommend minimal surgical intervention may need to be revised to include alternative strategies for the elimination or management of this pathology.
Copyright © 2010 Mosby, Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20674404     DOI: 10.1016/j.tripleo.2010.04.023

Source DB:  PubMed          Journal:  Oral Surg Oral Med Oral Pathol Oral Radiol Endod        ISSN: 1079-2104


  27 in total

Review 1.  Osteochemonecrosis: an overview.

Authors:  John Hellstein
Journal:  Head Neck Pathol       Date:  2014-11-20

2.  Prevalence of radiographic findings on jaws exposed to antiresorptive therapy: a meta-analysis.

Authors:  Kamile Leonardi Dutra; Letícia Fernanda Haas; Glaucia S Zimmermann; Gilberto Melo; Mariana Comparotto Minamisako; Carlos Flores-Mir; Márcio Corrêa
Journal:  Dentomaxillofac Radiol       Date:  2018-11-07       Impact factor: 2.419

3.  CT imaging features of antiresorptive agent-related osteonecrosis of the jaw/medication-related osteonecrosis of the jaw.

Authors:  Akira Baba; Tazuko K Goto; Hiroya Ojiri; Mutsumi Takagiwa; Chiho Hiraga; Masahiro Okamura; Sho Hasegawa; Yumi Okuyama; Nobuhiro Ogino; Hideomi Yamauchi; Yuko Kobashi; Shinji Yamazoe; Yohei Munetomo; Takuji Mogami; Takeshi Nomura
Journal:  Dentomaxillofac Radiol       Date:  2018-02-13       Impact factor: 2.419

4.  Interrelationship of clinical, radiographic and haematological features in patients under bisphosphonate therapy.

Authors:  Valesca S Koth; Maria A Figueiredo; Fernanda G Salum; Karen Cherubini
Journal:  Dentomaxillofac Radiol       Date:  2017-02-17       Impact factor: 2.419

5.  Mandibular inferior cortical bone thickness on panoramic radiographs in patients using bisphosphonates.

Authors:  Sandra R Torres; Curtis S K Chen; Brian G Leroux; Peggy P Lee; Lars G Hollender; Michelle Lloid; Shane Patrick Drew; Mark M Schubert
Journal:  Oral Surg Oral Med Oral Pathol Oral Radiol       Date:  2015-02-14

6.  Radiographic evidence of treatment with bisphosphonates.

Authors:  M L T Thayer
Journal:  Br Dent J       Date:  2017-04-07       Impact factor: 1.626

Review 7.  Serum C-terminal cross-linking telopeptide level as a predictive biomarker of osteonecrosis after dentoalveolar surgery in patients receiving bisphosphonate therapy: Systematic review and meta-analysis.

Authors:  Mohamed E Awad; Christina Sun; Joshua Jernigan; Mohammed Elsalanty
Journal:  J Am Dent Assoc       Date:  2019-06-28       Impact factor: 3.634

8.  Are there any differences in mandibular morphology of patients with bisphosphonate-related osteonecrosis of jaws?: a case-control study.

Authors:  Gozde Ozcan; Ahmet E Sekerci; Zeynep B Gönen
Journal:  Dentomaxillofac Radiol       Date:  2016-05-16       Impact factor: 2.419

Review 9.  Detecting the earliest radiological signs of bisphosphonate-related osteonecrosis.

Authors:  H Devlin; J Greenwall-Cohen; J Benton; T L Goodwin; A Littlewood; K Horner
Journal:  Br Dent J       Date:  2017-11-17       Impact factor: 1.626

10.  Associations between Systemic Markers of Bone Turnover or Bone Mineral Density and Anti-Resorptive Agent-Related Osteonecrosis of the Jaw in Patients Treated with Anti-Resorptive Agents.

Authors:  Kazuhito Tohashi; Motoki Nakabayashi; Isamu Kodani; Kazunori Kidani; Kazuo Ryoke
Journal:  Yonago Acta Med       Date:  2016-04-01       Impact factor: 1.641

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.